Together, these observations implicate age-associated expression of hepatocyte CD44, known for its role in liver cancer initiation24,26, in activation of the immune suppressive IL6/JAK/STAT3 pathway and T cell dysfunction in the aged liver. The gene discussed is CD44; the disease is liver cancer.